Neurocognitive impairment in type 2 diabetes: evidence for shared genetic aetiology

Aims/hypothesis Type 2 diabetes is associated with cognitive impairments, but it is unclear whether common genetic factors influence both type 2 diabetes risk and cognition. Methods Using data from 1892 Mexican-American individuals from extended pedigrees, including 402 with type 2 diabetes, we exam...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetologia 2020-05, Vol.63 (5), p.977-986
Hauptverfasser: Mollon, Josephine, Curran, Joanne E., Mathias, Samuel R., Knowles, Emma E. M., Carlisle, Phoebe, Fox, Peter T., Olvera, Rene L., Göring, Harald H. H., Rodrigue, Amanda, Almasy, Laura, Duggirala, Ravi, Blangero, John, Glahn, David C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aims/hypothesis Type 2 diabetes is associated with cognitive impairments, but it is unclear whether common genetic factors influence both type 2 diabetes risk and cognition. Methods Using data from 1892 Mexican-American individuals from extended pedigrees, including 402 with type 2 diabetes, we examined possible pleiotropy between type 2 diabetes and cognitive functioning, as measured by a comprehensive neuropsychological test battery. Results Negative phenotypic correlations ( ρ p ) were observed between type 2 diabetes and measures of attention (Continuous Performance Test [CPT d′]: ρ p  = −0.143, p  = 0.001), verbal memory (California Verbal Learning Test [CVLT] recall: ρ p  = −0.111, p  = 0.004) and face memory (Penn Face Memory Test [PFMT]: ρ p  = −0.127, p  = 0.002; PFMT Delayed: ρ p   =  −0.148, p  = 2 × 10 − 4 ), replicating findings of cognitive impairment in type 2 diabetes. Negative genetic correlations ( ρ g ) were also observed between type 2 diabetes and measures of attention (CPT d′: ρ g  = −0.401, p  = 0.001), working memory (digit span backward test: ρ g  = −0.380, p  = 0.005), and face memory (PFMT: ρ g  = −0.476, p  = 2 × 10 − 4 ; PFMT Delayed: ρ g  = −0.376, p  = 0.005), suggesting that the same genetic factors underlying risk for type 2 diabetes also influence poor cognitive performance in these domains. Performance in these domains was also associated with type 2 diabetes risk using an endophenotype ranking value approach. Specifically, on measures of attention (CPT d′: β  = −0.219, p  = 0.005), working memory (digit span backward: β  = −0.326, p  = 0.035), and face memory (PFMT: β  = −0.171, p  = 0.023; PFMT Delayed: β  = −0.215, p  = 0.005), individuals with type 2 diabetes showed the lowest performance, while unaffected/unrelated individuals showed the highest performance, and those related to an individual with type 2 diabetes performed at an intermediate level. Conclusions/interpretation These findings suggest that cognitive impairment may be a useful endophenotype of type 2 diabetes and, therefore, help to elucidate the pathophysiological underpinnings of this chronic disease. Data availability The data analysed in this study is available in dbGaP: www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001215.v2.p2 .
ISSN:0012-186X
1432-0428
DOI:10.1007/s00125-020-05101-y